Integration has its challenges and drawbacks, but, if successful, Portugal can act as a gateway to significant opportunities, sources say.

Gilead Sciences Inc. company and executive profile by Barron's. View the latest GILD company infomation and executive bios.

Immunosuppression, characterised by impaired immune function, significantly influences infection risk and ICU admissions in critically ill patients. This manuscript highlights the need for grading ...

Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal mandate that requires health insurers to cover preventive care services including those for reducing HIV risk and ...

Shares of Gilead Sciences Inc. GILD rallied 2.83% to $110.67 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.52% to 6,173 ...

Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage trials of obeldesivir.

Elinzanetant benefits were assessed in younger and older women with moderate hot flashes.

The FDA approved Gilead Sciences ’ new medicine, lenacapavir, a long-acting antiviral that treats HIV. The agency approved Daiichi Sanyo and AstraZeneca ’s Datroway for patients with previously ...